Substrate Selectivity Assessment

Substrate selectivity assessment evaluates enzyme specificity for intended substrates versus off-target alternatives. Enzymatic activity measurement across diverse substrates quantitates selectivity. Kinetic parameters including Vmax and Km characterise selectivity. Inhibition specificity assessment confirms selectivity. Therapeutic selectivity depends on substrate specificity.

Off-target enzyme inhibition produces toxicity. Selectivity optimisation guides therapeutic development. Regulatory submissions justify selectivity claims. Post-approval monitoring confirms selectivity maintenance. Emerging biochemistry improves selectivity assessment.